Senior insider sale
Chief Commercial Officer at IRONWOOD PHARMACEUTICALS INC — senior position signals high conviction
$91.2K
19.77K shares
GASKINS TAMMI L plans to sell 19.77K shares of IRONWOOD PHARMACEUTICALS INC valued at approximately $91.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements
Nasdaq
Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements
N/A
Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements
N/A
Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/27/2025 | Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements Nasdaq | 27.78K | — |
2/22/2024 | Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements N/A | 6.83K | — |
2/23/2023 | Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements N/A | 8.90K | — |
2/24/2022 | Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements N/A | 8.48K | — |
| Total | 51.99K | ||
Units to sell
19.77K
Market value
$91.2K
Units
19.77K
Value
$91.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/23/2026 | 19.77K | $91.2K | Nasdaq | Planned |
| Total | 19.77K | $91.2K | ||